Organisation paid for research Program year 2024 Source: CMS Open Payments

Empire Neurology PC

Neither a doctor nor a teaching hospital

Research payments

$832,299

134 payments

Through program year 2024, Empire Neurology PC is reported as receiving $832,299 in research payments, across 134 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$51,130	1
2022	Research	$19,338	2
2021	Research	$93,545	20
2020	Research	$217,744	50
2019	Research	$450,542	61

Breakdown

Who paid Research payments · program years 2019–2024

Genentech, Inc. $651,831 113 payments
F. Hoffmann-La Roche AG $170,542 12 payments
EMD Serono, Inc. $5,697 8 payments
Eli Lilly and Company $4,228 1 payment

Studies the money was for Research payments · program years 2019–2024

MNT Oboe $270,294 31 payments
Phase II Study of Anti Tau in Prodromal to Mild Ad $162,330 47 payments
MNT Chords $136,799 12 payments
Second Phase III in RMS $119,412 11 payments
Primary Ms $113,934 17 payments
Phase II Study for Moderate Ad $19,605 7 payments
Evaluating the Long-Term Outcomes and Durability of Effect following treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV ambispective study of patients who previously participated in the CLARITY/CLARITY-EXT and ORACLE Trials $5,697 8 payments
A 24-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of Azd3293 in Early Alzheimers Disease -The Amaranth Study $4,228 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.